Christine Engeland

In Experimental Virology, we investigate virus-host interactions and use these findings to research new therapeutic approaches. In particular, we are investigating the measles virus and its vaccine strain. One focus is on cancer immunotherapy using these vaccine viruses. To this end, the vaccine viruses are specifically modified in order to develop safe and effective therapeutics.

Research projects

• Mechanisms of measles vaccine virus-mediated anti-tumour immunity (see website)
• Host factors as antiviral targets and predictive markers of oncolytic therapy (see website)
• New viral vectors for tumour immunotherapy (see website)

• Maximiliane Finkbeiner, Research Assistant
• Linda Küther, Technical Assistant
• Gemma Pidalaserra Martin, Research Assistant
• Ferdinand Haas, academic staff member
• Lara Storath, Medical student

2004 - 2010
Study of medicine, University of Heidelberg

2012
Doctoral studies (Dr med.), University of Heidelberg

2014
Doctoral studies (Dr.rer.nat.), University of Heidelberg/DKFZ

2015 - 2018
Laboratory Manager, National Centre for Tumour Diseases (NCT) Heidelberg

2019 - 2020
Head of Research Group "Mechanisms of Oncolytic Immunotherapy", DKFZ Heidelberg

Since 5/2020
Professorship of Experimental Virology, Witten/Herdecke University

Specialisations:

Virology and microbiology

Events:

Lecture series Molecular Medicine

• Virology,
• immunotherapy,
• vaccination,
• oncolytic viruses

Co-operations:

• German Cancer Research Centre Heidelberg
• University of Leipzig
• Fraunhofer Institute for Cell Therapy and Immunology
• National Centre for Tumour Diseases Dresden
• HELIOS Medical Centre Wuppertal
• Ulm University Hospital
• Queensland University of Technology
• Moffitt Cancer Centre, Tampa, Florida